Paper · 40892829
Conservation and divergence of ciprofloxacin persister survival mechanisms between Pseudomonas aeruginosa and Escherichia coli.
Leon G and 1 other. PLoS Genet, 2025. Cited by 4 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Conservation and divergence of ciprofloxacin persister survival mechanisms between Pseudomonas aeruginosa and Escherichia coli. Papers, record 40892829. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40892829
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Conservation and divergence of ciprofloxacin persister survival mechanisms between Pseudomonas aeruginosa and Escherichia coli.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Pseudomonas aeruginosa | Major topic |
| Ciprofloxacin | Major topic |
| Escherichia coli | Major topic |
| SOS Response, Genetics | |
| Anti-Bacterial Agents | |
| Humans | |
| DNA Damage | |
| Pseudomonas Infections | |
| Drug Resistance, Bacterial | |
| Homologous Recombination | |
| DNA Repair | |
| Cystic Fibrosis | |
| DNA End-Joining Repair |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R21 AI182745 | NIAID NIH HHS | United States | R21AI182745 | PubMed and NIH | NIH RePORTER |
| R21 AI185486 | NIAID NIH HHS | United States | R21AI185486 | PubMed and NIH | NIH RePORTER |
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References74
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27,105,118 | Enhanced Efflux Activity Facilitates Drug Tolerance in Dormant Bacterial Cells. | Mol Cell | 2016 | https://conductscience.org/library/papers/27105118 | PubMed |
| 2 | 39,374,386 | Tracking the progeny of bacterial persisters using a CRISPR-based genomic recorder. | Proc Natl Acad Sci U S A | 2024 | https://conductscience.org/library/papers/39374386 | PubMed |
| 3 | 30,980,069 | Definitions and guidelines for research on antibiotic persistence. | Nat Rev Microbiol | 2019 | https://conductscience.org/library/papers/30980069 | PubMed |
| 4 | 34,097,492 | The AcrAB-TolC Efflux Pump Impacts Persistence and Resistance Development in Stationary-Phase Escherichia coli following Delafloxacin Treatment. | Antimicrob Agents Chemother | 2021 | https://conductscience.org/library/papers/34097492 | PubMed |
| 5 | 20,616,014 | Structure of bacterial LigD 3'-phosphoesterase unveils a DNA repair superfamily. | Proc Natl Acad Sci U S A | 2010 | https://conductscience.org/library/papers/20616014 | PubMed |
| 6 | 38,564,687 | Differential impacts of DNA repair machinery on fluoroquinolone persisters with different chromosome abundances. | mBio | 2024 | https://conductscience.org/library/papers/38564687 | PubMed |
| 7 | 160,562 | Identification of the lexA gene product of Escherichia coli K-12. | Proc Natl Acad Sci U S A | 1979 | https://conductscience.org/library/papers/160562 | PubMed |
| 8 | 9,293,187 | DNA gyrase, topoisomerase IV, and the 4-quinolones. | Microbiol Mol Biol Rev | 1997 | https://conductscience.org/library/papers/9293187 | PubMed |
| 9 | 11,445,083 | Identification of bacterial homologues of the Ku DNA repair proteins. | FEBS Lett | 2001 | https://conductscience.org/library/papers/11445083 | PubMed |
| 10 | 30,647,458 | Bacterial persistence promotes the evolution of antibiotic resistance by increasing survival and mutation rates. | ISME J | 2019 | https://conductscience.org/library/papers/30647458 | PubMed |
1 to 10 of 74
See all 74 referencesCited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,766,644 | Genetic analysis of epistasis between nucleotide excision repair and homologous recombination in the recovery of persisters after fluoroquinolone treatment. | PLoS Genet | 2026 | https://conductscience.org/library/papers/42766644 | PubMed |
| 42,489,447 | Contributions of persisters and the Eagle effect to survival of Yersinia pseudotuberculosis under clinical antimicrobials. | Microbiol Spectr | 2026 | https://conductscience.org/library/papers/42489447 | PubMed |
| 42,306,942 | Non-canonical double-stranded DNA break repair in Pseudomonas aeruginosa includes LigD-independent non-homologous end joining. | Nucleic Acids Res | 2026 | https://conductscience.org/library/papers/42306942 | PubMed |
| 41,400,384 | Stationary-phase Pseudomonas aeruginosa fluoroquinolone persisters mostly avoid DNA double-stranded breaks. | mSphere | 2026 | https://conductscience.org/library/papers/41400384 | PubMed |
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40892829
GET https://conductscience.org/api/papers/v1/40892829/references?page=2